Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

844.27 -26.09 (-3.00%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,222,380
Open 869.10
Bid (Size) 842.55 (1)
Ask (Size) 848.00 (2)
Prev. Close 870.36
Today's Range 841.49 - 873.50
52wk Range 711.40 - 972.53
Shares Outstanding N/A
Dividend Yield 0.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
Via The Motley Fool
MarketBeat Week in Review – 02/10 - 02/14
Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in 
Via MarketBeat
Topics Credit Cards Economy Government
Exposures Interest Rates Political Tariff

Performance

YTD
+8.51%
+8.51%
1 Month
+11.44%
+11.44%
3 Month
+16.10%
+16.10%
6 Month
-8.41%
-8.41%
1 Year
+7.95%
+7.95%

More News

Read More
Top Stock Reports For Apple, Eli Lilly & Shopify
Via Talk Markets
Topics Stocks / Equities
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Via MarketBeat
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
Via The Motley Fool
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
Via MarketBeat
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Healthcare And Biotech Playbook As Disruption Gathers Force
Via Talk Markets
Topics ETFs Stocks / Equities
2 Growth Stocks to Buy Hand Over Fist in February
Via The Motley Fool
Is Novo Nordisk Stock a Buy Now?
Via The Motley Fool
Looking Into Eli Lilly's Recent Short Interest
Via Benzinga
Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals
Via Benzinga
5 ETFs That Beat Market Turmoil With Gains Last Week
Via Benzinga
Topics ETFs Economy
Exposures Interest Rates
These Stocks Missed on Earnings, But Will Rebound Next Quarter
Via MarketBeat
Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight
Via Stocktwits
Market Monitor February 6th
Via Chartmill
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
How To Ride The Market’s “Great Risk Rollercoaster”
Via Talk Markets
Topics ETFs Stocks / Equities
Magnificent Seven Slip, Inflation Fears Grip Consumers, Gold Hits Record Highs: This Week In The Markets
Via Benzinga
Topics Economy
Exposures Interest Rates
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
Via Investor's Business Daily
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
Via Benzinga
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Via Stocktwits
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.